Related Experiment Video
Updated: Aug 14, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation
1Institut für Toxikologie, Universität Würzburg, Germany.
Abstract:
Evidence has been accumulating that several classes of compounds are converted by glutathione conjugate formation to toxic metabolites. The aim of this review is to summarize the current knowledge on the biosynthesis and toxicity of glutathione S-conjugates derived from halogenated alkenes, and hydroquinones and quinones. Different types of toxic glutathione conjugates have been identified in detail; (i) conjugates which are converted to toxic metabolites in an enzyme-catalyzed multistep mechanism and (ii) conjugates which serve as a transport form for toxic quinones will be discussed. The kidney is the main, with some compounds the exclusive, target organ for compounds metabolized by these pathways. Selective toxicity to the kidney is easily explained due to the capability of the kidney to accumulate intermediates formed by processing of S-conjugates and to bioactivate these intermediates to toxic metabolites. The influences of other factors participating in the renal susceptibility and influencing human risk assessment for these compounds are discussed.
Insights
Glutathione S-conjugates from certain chemicals can form toxic metabolites, primarily targeting the kidney. This review details their formation, toxicity, and implications for human risk assessment.
Area of Science:
- Toxicology
- Biochemistry
- Environmental Health
Background:
- Glutathione conjugate formation is a known pathway for generating toxic metabolites from various chemical classes.
- Halogenated alkenes, hydroquinones, and quinones are key examples of compounds metabolized via glutathione conjugation.
- The kidney is frequently identified as the primary target organ for these toxic metabolic pathways.
Purpose of the Study:
- To review the current knowledge on the biosynthesis and toxicity of glutathione S-conjugates.
- To discuss the mechanisms by which these conjugates lead to toxic metabolites.
- To explore the factors influencing kidney susceptibility and human risk assessment.
Main Methods:
- Literature review and synthesis of existing research on glutathione S-conjugates.
- Analysis of biochemical pathways involved in the bioactivation of glutathione conjugates.
- Examination of toxicological data and epidemiological studies related to target organ toxicity.
Main Results:
- Two main types of toxic glutathione conjugates identified: those converted to toxic metabolites and those acting as transport forms for toxic quinones.
- The kidney's capacity to accumulate and bioactivate intermediates of S-conjugate processing explains its selective toxicity.
- Various factors influencing renal susceptibility and human risk assessment have been elucidated.
Conclusions:
- Glutathione S-conjugate formation is a critical toxicological pathway with significant implications for kidney damage.
- Understanding these pathways is essential for accurate human risk assessment of exposed populations.
- Further research into modulating factors could lead to improved protective strategies.
More Related Videos
Related Concept Videos
Drug Metabolism: Phase II Reactions
Phase II Reactions: Glucuronidation
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Bioactivation and Tissue Toxicity

